Hanmi Flu outnumbers Tamiflu in flu medicine market

Published: 2016-12-23 13:59:34

Updated: 2016-12-23 13:59:34

The market share of ‘Hanmi Flu,’ a Korean influenza treatment, exceeded 50%.

According to Hanmi Pharm on the 21^st, after the flu watch was alerted, its prescriptions were rapidly increased, which made the market share 54.9% in the first week of December and outnumbered the market share of Tamiflu, a foreign drug. (the amount of prescriptions in the 1^st week of December based on UBIST: Hanmi Fl...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.